Figure 3From: Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor AntagonismMean posttreatment VAS scores over time for icatibant and comparator treatment of acute HAE episodes in the randomized, double-blind FAST 1 and FAST 2 studies. Source: European Medicines Agency (http://www.ema.europa.eu/humandocs/PDFs/EPAR/firazyr/H-899-en6.pdf).Back to article page